Exhibiting at VIV Asia 2025

Uni Biotech Co., Ltd. is a Korean-based manufacturer specializing in the development and production of animal health pharmaceuticals and feed additives. With a commitment to advancing livestock productivity and disease prevention, Uni Biotech has established itself as a trusted provider of veterinary solutions across domestic and international markets. Headquartered in Yesan, Republic of Korea, the company integrates innovation, regulatory compliance, and technical support to deliver safe and effective products for animal health and performance.

Corporate Overview

Founded with the vision of improving animal well-being through science-based products, Uni Biotech operates in alignment with global standards for Good Manufacturing Practices (GMP) and veterinary pharmaceutical production. The company focuses on producing high-quality antibiotic formulations, anthelmintics, antibacterial agents, nutritional supplements, and feed additives targeted for swine, poultry, cattle, and companion animals.

The leadership team, headed by CEO Jun Hui Cho, brings decades of industry experience in pharmacology, animal nutrition, and regulatory affairs, guiding the company through continuous innovation and strategic market expansion.

Product Portfolio

Uni Biotech offers a diverse and targeted range of products within the animal health sector:

• Antibiotics: Formulated to treat and prevent bacterial infections in livestock, including broad-spectrum agents for swine and poultry respiratory and enteric diseases.

• Antibacterial Agents: Topical and oral solutions designed for hygiene and pathogen control, supporting livestock health management practices.

• Anthelmintics: Deworming medications for the control of gastrointestinal and tissue parasites in ruminants and pigs, including oral drenches and injectables.

• Nutritional Supplements: Vitamins, trace minerals, and electrolytes developed to optimize animal growth, immunity, and feed conversion rates.

• Feed Additives: Products that enhance digestion, reduce pathogen load, and improve feed efficiency, including probiotics, acidifiers, and enzyme blends.

These products are manufactured under rigorous quality control measures and comply with local and international safety regulations.

Manufacturing and Quality Control

Uni Biotech’s production facilities are designed to meet international veterinary pharmaceutical manufacturing standards. Key features include:

• GMP-certified cleanrooms and compounding units
• Automated dosing and mixing systems
• In-house analytical laboratories for quality assurance
• Standardized batch tracking and documentation systems

Each production lot undergoes a stringent quality verification process to ensure compliance with Korean Ministry of Agriculture, Food and Rural Affairs (MAFRA) regulations and, where applicable, Codex and OIE standards for export markets.

Market Reach and Export Strategy

Although headquartered in South Korea, Uni Biotech has steadily expanded its footprint into global markets through licensing partnerships and export operations. Its international business strategy is focused on:

• Southeast Asia: Expanding demand in Vietnam, Thailand, and the Philippines
• Middle East: Strategic partnerships in Saudi Arabia and UAE for livestock solutions
• Africa and Latin America: Opportunities in poultry and swine production centers

The company supports its overseas clients through multilingual documentation, regulatory guidance, and customized product registration assistance.

R&D and Innovation

Uni Biotech maintains a dedicated R&D division focused on:

• Developing antibiotic alternatives in response to antimicrobial resistance (AMR) trends
• Enhancing bioavailability of feed additives using microencapsulation technology
• Researching synergistic formulations combining vitamins, enzymes, and probiotics
• Collaborating with academic institutions for field trials and efficacy studies

In recent years, Uni Biotech has prioritized natural and plant-based compounds to align with consumer demand for antibiotic-free animal products and organic farming systems.

Regulatory Compliance and Certifications

The company holds key regulatory accreditations required for domestic and international operations:

• Korean GMP certification for veterinary pharmaceutical manufacturing
• Product approvals from the Animal and Plant Quarantine Agency (APQA)
• Participation in Korea’s Ministry of Food and Drug Safety (MFDS) monitoring programs
• Adherence to HACCP standards in applicable production lines

These certifications support the company’s eligibility to operate in highly regulated markets and ensure product safety and traceability.

Customer Engagement and Technical Support

Uni Biotech invests in customer success through:

• On-site veterinary training and product usage workshops
• Technical support teams providing guidance on dosage protocols and formulation customization
• Distribution partnerships with licensed veterinary pharmacies and agro-supply chains
• Development of multilingual product manuals and technical datasheets for international users

The company’s support infrastructure ensures proper product application and contributes to reduced mortality, improved feed efficiency, and overall herd/flock health for clients.

Strategic Vision and Growth

Uni Biotech’s growth strategy includes:

• Expanding its GMP manufacturing capacity by 20% over the next three years
• Launching new functional feed additive lines targeting gut health and growth promotion
• Strengthening presence in global halal-compliant veterinary product markets
• Increasing digital engagement through virtual product presentations and distributor portals

As the livestock sector continues to evolve in response to food security demands, Uni Biotech aims to become a global partner in responsible animal care through safe, science-backed solutions that improve productivity and sustainability.

Through its commitment to innovation, quality, and customer-centric operations, Uni Biotech Co., Ltd. is helping to shape the future of animal health in Korea and beyond.